Inside Drug Pricing - 04/08/2019

White House Budget Staff Reviewing Protected Drug Classes Rule

By John Wilkerson / April 4, 2019 at 12:19 PM
The White House budget staff are reviewing CMS’ final rule to lower Part D drug costs, which might include eliminating coverage protections in six drug classes, according to the Office of Management and Budget website. CMS in November proposed changes to Part D that would let plans exclude drugs in protected classes from formularies when their makers hike prices faster than inflation or when drug companies make new formulations of drugs already on the market. The proposed rule also would...


Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on drug pricing reforms, Medicaid policy, FDA news and much more.